Single Autosomal Trisomy in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Current Genomics ◽

10.2174/1389202003351553 ◽

2000 ◽

Vol 1 (2) ◽

pp. 153-173 ◽

Author(s):

S. Ma ◽

T. Wan

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Autosomal Trisomy ◽

Download Full-text

Decision letter for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v3/decision1 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Population Based Study ◽

Incidence Risk ◽

Download Full-text

Author response for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v2/response1 ◽

2019 ◽

Author(s):

Xingnong Ye ◽

Dan Chen ◽

Yan Zheng ◽

Cai Wu ◽

Xiaoqiong Zhu ◽

...

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Author Response ◽

Population Based Study ◽

Incidence Risk ◽

Download Full-text

Decision letter for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v2/decision1 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Population Based Study ◽

Incidence Risk ◽

Download Full-text

Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome

10.32388/p7v2fx ◽

2020 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Alkylating Agent ◽

Download Full-text

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

Case Medical Research ◽

10.31525/ct1-nct03940352 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Download Full-text

Pembrolizumab and Decitabine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

Case Medical Research ◽

10.31525/ct1-nct03969446 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

Download Full-text

Faculty Opinions recommendation of Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10197.467594 ◽

2006 ◽

Author(s):

Mayumi Mori

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Prognostic Models ◽

Intensive Chemotherapy ◽

Download Full-text

Faculty Opinions recommendation of A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1119427.575617 ◽

2008 ◽

Author(s):

Arati Rao

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Low Dose ◽

Randomized Study ◽

Line Therapy ◽

Low Dose Cytarabine ◽

Download Full-text

Faculty Opinions recommendation of Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737669231.793578956 ◽

2020 ◽

Author(s):

Livio Pagano

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Prospective Phase ◽

Anti Fungal ◽

Download Full-text

Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome

Journal of the Formosan Medical Association ◽

10.1016/j.jfma.2020.12.021 ◽

2021 ◽

Author(s):

Sheng-Hsuan Chien ◽

Ming Yao ◽

Chi-Cheng Li ◽

Ping-Ying Chang ◽

Ming-Sun Yu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Myelodysplastic Syndrome ◽

Charlson Comorbidity Index ◽

Myeloid Leukemia ◽

Hematopoietic Stem ◽

Comorbidity Index ◽

Download Full-text